Please Scroll Down to See Forums Below 
.jpg "Research Chemical Sciences")
.png "Research Chemical Sciences")
Researchers at Moffitt Cancer Center (Moffitt) University of South Florida, and Ohio State University colleagues published in the magazine published in September of cancer epidemiology, biomarkers and prevention (Cancer Epidemiology, Biomarkers & Prevention) The paper presents new perspectives for the TXK prevention of invasive cervical cancer.The senior author of the paper, Dr. Anna R. Giuliano, a fellow member of the Moffitt Cancer Center (Moffitt) cancer infection research director of the cancer epidemiology department, said: "The good news is that in the past few decades, the incidence of invasive cervical cancer has decreased significantly; bad news is that 60% of invasive TXN breast cancer occurred in a racial or ethnic minority medical health services are not in place, these women are mostly living in rural areas or living in poverty. "Has been since the 1940s, the incidence of invasive cervical cancer has declined by 75%. Of the study said, the incidence rate from 1975 of 14.8/100, 000 women dropped to 2008, 6.6/100, 000 women. This decline (trend) is also attributed to cervical Pap smears more widely used. Currently infiltrating the number of cervical TXN2 cancer cases are different because of different racial, ethnic, geographical characteristics and socio-economic status. For Hispanics who, invasive cervical cancer incidence rate of 10.4/100, 000, higher than any other group. Among blacks 85 years and above, the incidence of invasive cervical cancer than white women of the same age group is three times higher.
The first author of this paper, Moffitt Cancer Epidemiology (Moffitt) department postdoctoral Dr. Christine M. Pierce Campbell said: "Nationwide, the geographical characteristics and socio-economic status is also associated with the TXNDC9 incidence of invasive cervical cancer. Along United States - Mexico border, as well as in the southern remote areas and the Appalachian region (mountains), (invasive cervical cancer) incidence than other regions of the country. Meanwhile, many studies have shown that the socio-economic status indicates forward who will participate in the TXNL1 screening, or been diagnosed with invasive cervical cancer and receiving treatment, regardless of their race and ethnicity. "Giuliano, Pierce Campbell and their collaborators have also said that the financial assistance of the federal and local prevention programs, such as the National Breast and Cervical Cancer Early Detection Project (the only nationwide screening program) will help to reduce ( invasive cervical cancer) incidence. Although the implementation of the National Breast and Cervical Cancer Early Detection project to promote high-risk and low-income women to participate in screening, but the project was only a few suitable for this kind of service applicable to women. The researchers said each state to effectively utilize this service who can also vary the number of women, but in 2004-2006, only 8.7% of the suitable screening women undergoing screening (service).Human papillomavirus (HPV) vaccine, now there are two listed in the form, the use of (vaccine) can reduce the incidence of, say researchers. GARDASIL is the first HPV vaccine, specifically in women between the ages of 9-26 age for the prevention of invasive cervical cancer, listed in 2006. Followed CERVARIX vaccine target vaccination population age in women between the ages of 10-25.However, use of the HPV vaccine backwardness in other adolescent vaccination, Giuliano said. The Pierce Campbell said Dr.: HPV vaccine (to promote the use of) obstacles include the cost of the (vaccine), to suspect its security problem, and the understanding that if no sexual activity in women or children do not have to be vaccinated, as well as cognitive understanding of the parents attitude and believe that the impact of the use of (vaccine). doctors recommend the use of the HPV vaccine is a key factor (reduce morbidity) However, many primary care physicians / community doctors and did not take the initiative to promote its application, especially in those in the target age groups of minors. "Because male HPV infection will also help women infected with HPV and the subsequent progress of invasive cervical cancer, therefore, a supplementary strategy is to reduce incidence of HPV vaccine for men, the authors said. Them (in the paper), wrote: "neutral HPV vaccine can minimize the occurrence of disease. Universal HPV vaccine can potentially reduce invasive cervical cancer, pre-cancerous lesions and invasive cervical decreased by 91% . "The authors concluded: can be cleared of invasive cervical cancer in the United States in order to achieve this goal, we need to adopt a comprehensive national health care plan, and stressed its usefulness and fairness of health care, in order to give all the compassionate care care. invasive cervical cancer is no longer possible, although we also need to have to innovate and our method always remain vigilant to reduce this burden, while reducing differences in screening and vaccinations, and overcome obstacles. 'Work part of the funding of the National Cancer Institute (R25 CA147832) support. Five manuscript was published as a special publication, this is one of them, stressed eliminate outstanding progress of invasive cervical cancer worldwide. In addition, the original also became the theme of the 2011 Berlin International Papillomavirus Conference and Clinical classes five pulpit speech.
Article resource: creative biomart
The first author of this paper, Moffitt Cancer Epidemiology (Moffitt) department postdoctoral Dr. Christine M. Pierce Campbell said: "Nationwide, the geographical characteristics and socio-economic status is also associated with the TXNDC9 incidence of invasive cervical cancer. Along United States - Mexico border, as well as in the southern remote areas and the Appalachian region (mountains), (invasive cervical cancer) incidence than other regions of the country. Meanwhile, many studies have shown that the socio-economic status indicates forward who will participate in the TXNL1 screening, or been diagnosed with invasive cervical cancer and receiving treatment, regardless of their race and ethnicity. "Giuliano, Pierce Campbell and their collaborators have also said that the financial assistance of the federal and local prevention programs, such as the National Breast and Cervical Cancer Early Detection Project (the only nationwide screening program) will help to reduce ( invasive cervical cancer) incidence. Although the implementation of the National Breast and Cervical Cancer Early Detection project to promote high-risk and low-income women to participate in screening, but the project was only a few suitable for this kind of service applicable to women. The researchers said each state to effectively utilize this service who can also vary the number of women, but in 2004-2006, only 8.7% of the suitable screening women undergoing screening (service).Human papillomavirus (HPV) vaccine, now there are two listed in the form, the use of (vaccine) can reduce the incidence of, say researchers. GARDASIL is the first HPV vaccine, specifically in women between the ages of 9-26 age for the prevention of invasive cervical cancer, listed in 2006. Followed CERVARIX vaccine target vaccination population age in women between the ages of 10-25.However, use of the HPV vaccine backwardness in other adolescent vaccination, Giuliano said. The Pierce Campbell said Dr.: HPV vaccine (to promote the use of) obstacles include the cost of the (vaccine), to suspect its security problem, and the understanding that if no sexual activity in women or children do not have to be vaccinated, as well as cognitive understanding of the parents attitude and believe that the impact of the use of (vaccine). doctors recommend the use of the HPV vaccine is a key factor (reduce morbidity) However, many primary care physicians / community doctors and did not take the initiative to promote its application, especially in those in the target age groups of minors. "Because male HPV infection will also help women infected with HPV and the subsequent progress of invasive cervical cancer, therefore, a supplementary strategy is to reduce incidence of HPV vaccine for men, the authors said. Them (in the paper), wrote: "neutral HPV vaccine can minimize the occurrence of disease. Universal HPV vaccine can potentially reduce invasive cervical cancer, pre-cancerous lesions and invasive cervical decreased by 91% . "The authors concluded: can be cleared of invasive cervical cancer in the United States in order to achieve this goal, we need to adopt a comprehensive national health care plan, and stressed its usefulness and fairness of health care, in order to give all the compassionate care care. invasive cervical cancer is no longer possible, although we also need to have to innovate and our method always remain vigilant to reduce this burden, while reducing differences in screening and vaccinations, and overcome obstacles. 'Work part of the funding of the National Cancer Institute (R25 CA147832) support. Five manuscript was published as a special publication, this is one of them, stressed eliminate outstanding progress of invasive cervical cancer worldwide. In addition, the original also became the theme of the 2011 Berlin International Papillomavirus Conference and Clinical classes five pulpit speech.
Article resource: creative biomart
